🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

We are delighted to share the news that TRH The Prince & Princess of Wales have today become Joint Patrons of The Royal Marsden. The announcement was made as part of a visit to our Chelsea hospital today, when we welcomed HRH The Princess of Wales to the Trust. The Prince and Princess of Wales

#RAIDER trial: Safety of tumor-directed dose escalation. 💡 Adaptive radiotherapy reshapes bladder cancer care! Dr. Robert Huddart💙 The ICR and Leslie Ballas discuss RAIDER trial findings: safe dose escalation, low toxicity, and preserved quality of life using tumor-directed

📢 Out Now! Tune in to a must-listen episode with Dr Anna Kirby! We delve into breast cancer radiotherapy trials and reflect on her role as ESTRO president! Anna Kirby The ICR MRC Clinical Trials Unit at UCL The Royal Marsden NHS Foundation Trust Hoda Abdel-Aty 💙 Nick James also on @Prof-Nick-James.bsky.social spotifycreators-web.app.link/e/rlerMLrfHQb

Robert Huddart💙 presenting intriguing data on combining pembrolizumab and radiation for locally advanced/metastatic bladder cancer: 24 Gy in 6 fractions, with 13/26 patients responding per RECIST and 8 achieving CR ASCO #GU25

🎯Amazing session on testicular cancer! So exciting to see new therapeutic approaches on the horizon. ✨CAR T-cells, ADCs, and bispecifics targeting Claudin 6 – the future is bright! #ASCOGU25 Dr. Darren Feldman Nabil Adra Robert Huddart💙 UroFocus OncoDaily

Robert Huddart💙 Paul Sargos Yüksel Ürün Thomas Zilli ASCO OncoAlert Clinical Cancer Research Matt Galsky Petros Grivas Emre Yekedüz Enrique Grande Syed A Hussain Elizabeth Plimack MD Alison Tree 💙 Tom Powles Daniel Castellano Nick James also on @Prof-Nick-James.bsky.social Agree Robert Huddart💙 Paul Sargos Results from contemporary #radiotherapy trials are as good as these with a lot less toxicity. I've said it before & I'll say it again - there's already an excellent alternative to cystectomy. #RAIDER sciencedirect.com/science/articl…

💫🌟🔬 Unraveling the Genetic Landscape of Testicular Germ Cell Tumors (TGCT)! 🧬🌟💫 ❗️Largest whole-exome meta-analysis in TGCT to date sheds light on genetic predisposition in 1,435 cases vs. 18,284 controls. #ZeidKuzbari Charlie Rowlands #IsaacWade #AliceGarrett Chey Loveday

#RAIDER trial: Safety of tumor-directed dose escalation. 💡 Adaptive radiotherapy reshapes bladder cancer care! Dr. Robert Huddart💙 The ICR and Leslie Ballas discuss RAIDER trial findings: safe dose escalation, low toxicity, and preserved quality of life using tumor-directed

[3/3] Robert Huddart, Fay Cafferty and Alison Reid received a Clinical Trial Award to assess circulating serum microRNA as a #biomarker for relapse in Phase 2/3 trial to reduce the burden of standard active surveillance in stage I germ cell tumours. #CRUKFunded #tyacancer

Adaptive radiotherapy in #BladderCancer: Phase II results from the #RAIDERII trial. Robert Huddart💙 The ICR joins Sam S. Chang MD, MBA Vanderbilt Urology to discuss. Daily imaging & tailored plans for improved treatment precision for 98% of patients with low toxicity & promising disease

One of the best scientific debates I’ve witnessed between Prof Mike Seckl Imperial NHS 💙 and Prof Robert Huddart💙 The Royal Marsden NHS Foundation Trust on management of brain mets in GCT patients. Thank you both for a superb session. #NGCGEaling25 National Germ Cell Group 💙

🎯 major takeaways from the brilliant presentation on bladder sparing treatment by Robert Huddart💙 #ESTRO2025

Great honor to be at #ESTRO25 to discuss the bladder sparing approach with medical tx alone in #MIBC. Challenging topic pending EV-P combo in EV304 study. Patient's selection remains critical. Robert Huddart💙 Valérie Fonteyne Giulio Francolini Stefano Arcangeli OncoAlert World Bladder Cancer Patient Coalition

Adaptive radiotherapy in #BladderCancer: Phase II results from the #RAIDERII trial. Robert Huddart💙 The ICR joins Sam S. Chang MD, MBA Vanderbilt Urology to discuss. Daily imaging & tailored plans for improved treatment precision for 98% of patients with low toxicity & promising disease

Excited to share that our narrative review on the management of testicular cancer is now online at JCO Oncology Practice Read here: ascopubs.org/doi/10.1200/OP… Daniele Raggi Robert Huddart💙 ASCO Journal of Clinical Oncology Testicular Cancer Testicular Cancer UK Testicular Cancer Society Check One Two - The lowdown on Testicular Cancer

Adaptive radiotherapy in #BladderCancer: Phase II results from the #RAIDERII trial. Robert Huddart💙 The ICR joins Sam S. Chang MD, MBA Vanderbilt Urology to discuss. Daily imaging & tailored plans for improved treatment precision for 98% of patients with low toxicity & promising disease